Bardoxolone-Methyl Prevents Oxidative Stress-Mediated Apoptosis and Extracellular Matrix Degradation in vitro and Alleviates Osteoarthritis in vivo

References

• LatourteA, KloppenburgM, RichetteP. Emerging pharmaceutical therapies for osteoarthritis. Nat Rev Rheumatol. 2020;16(12):673–688. doi:10.1038/s41584-020-00518-633122845
   PubMed Web of Science ®Google Scholar
• HuY, ChenX, WangS, JingY, SuJ. Subchondral bone microenvironment in osteoarthritis and pain. Bone Res. 2021;9(1):20. doi:10.1038/s41413-021-00147-z33731688
   PubMed Web of Science ®Google Scholar
• FangT, ZhouX, JinM, NieJ, LiX. Molecular mechanisms of mechanical load-induced osteoarthritis. Int Orthop. 2021;1:548.
   Google Scholar
• McClurgO, TinsonR, TroebergL. Targeting cartilage degradation in osteoarthritis. Pharmaceuticals. 2021;14(2):584.34207179
   PubMed Web of Science ®Google Scholar
• JiangW, LiuH, WanR, WuY, ShiZ, HuangW. Mechanisms linking mitochondrial mechanotransduction and chondrocyte biology in the pathogenesis of osteoarthritis. Ageing Res Rev. 2021;67:101315. doi:10.1016/j.arr.2021.10131533684550
   PubMed Web of Science ®Google Scholar
• HwangHS, KimHA. Chondrocyte apoptosis in the pathogenesis of osteoarthritis. Int J Mol Sci. 2015;16(11):26035–26054. doi:10.3390/ijms16112594326528972
   PubMed Web of Science ®Google Scholar
• HosseinzadehA, KamravaSK, JoghataeiMT, et al. Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin. J Pineal Res. 2016;61(4):411–425. doi:10.1111/jpi.1236227555371
   PubMed Web of Science ®Google Scholar
• CharlierE, RelicB, DeroyerC, et al. Insights on molecular mechanisms of chondrocytes death in osteoarthritis. Int J Mol Sci. 2016;17(12):2146. doi:10.3390/ijms17122146
   PubMed Web of Science ®Google Scholar
• Pérez-LozanoML, CesaroA, MazorM, et al. Emerging natural-product-based treatments for the management of osteoarthritis. Antioxidants. 2021;10(2):796.34069820
   PubMed Web of Science ®Google Scholar
• CuadradoA, MandaG, HassanA, et al. Transcription Factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach. Pharmacol Rev. 2018;70(2):348–383. doi:10.1124/pr.117.01475329507103
   PubMed Web of Science ®Google Scholar
• TianC, GaoL, ZhangA, HackfortBT, ZuckerIH. Therapeutic effects of Nrf2 activation by bardoxolone methyl in chronic heart failure. J Pharmacol Exp Ther. 2019;371(3):642–651. doi:10.1124/jpet.119.26179231601682
   PubMed Web of Science ®Google Scholar
• PeiX, ZhangXJ, ChenHM. Bardoxolone treatment alleviates lipopolysaccharide (LPS)-induced acute lung injury through suppressing inflammation and oxidative stress regulated by Nrf2 signaling. Biochem Biophys Res Commun. 2019;516(1):270–277.31248593
   PubMed Web of Science ®Google Scholar
• KandaH, YamawakiK. Bardoxolone methyl: drug development for diabetic kidney disease. Clin Exp Nephrol. 2020;24(10):857–864. doi:10.1007/s10157-020-01917-532594372
   PubMed Web of Science ®Google Scholar
• NagasuH, SogawaY, KidokoroK, et al. Bardoxolone methyl analog attenuates proteinuria-induced tubular damage by modulating mitochondrial function. FASEB J. 2019;33(11):12253–12263. doi:10.1096/fj.201900217R31431054
   PubMed Web of Science ®Google Scholar
• KalvalaAK, KumarR, SherkhaneB, GunduC, ArruriVK, KumarA. Bardoxolone Methyl Ameliorates Hyperglycemia Induced Mitochondrial Dysfunction by Activating the keap1-Nrf2-ARE Pathway in Experimental Diabetic Neuropathy. Mol Neurobiol. 2020;57(8):3616–3631. doi:10.1007/s12035-020-01989-032556916
   PubMed Web of Science ®Google Scholar
• KamelAM, BowlinS, AnwarB, ReichardH, ArgusJ, BlairIA. In vitro biotransformation of the Nrf2 activator bardoxolone: formation of an epoxide metabolite that undergoes two novel glutathione-mediated metabolic pathways: epoxide reduction and oxidative elimination of nitrile moiety. Chem Res Toxicol. 2019;32(11):2268–2280. doi:10.1021/acs.chemrestox.9b0028931613099
   PubMed Web of Science ®Google Scholar
• DingSL, PangZY, ChenXM, et al. Urolithin a attenuates IL-1β-induced inflammatory responses and cartilage degradation via inhibiting the MAPK/NF-κB signaling pathways in rat articular chondrocytes. J Inflammation. 2020;17:13. doi:10.1186/s12950-020-00242-8
   Google Scholar
• XuC, ZhuS, WuM, ZhaoY, HanW, YuY. The therapeutic effect of rhMK on osteoarthritis in mice, induced by destabilization of the medial meniscus. Biol Pharm Bull. 2014;37(11):1803–1810. doi:10.1248/bpb.b14-0047025366485
   PubMed Web of Science ®Google Scholar
• TateiwaD, YoshikawaH, KaitoT. Cartilage and bone destruction in arthritis: pathogenesis and treatment strategy: a literature review. Cells. 2019;8(8). doi:10.3390/cells8080818
   Web of Science ®Google Scholar
• BoehmeKA, RolauffsB. Onset and progression of human osteoarthritis-can growth factors, inflammatory cytokines, or differential miRNA Expression Concomitantly Induce Proliferation, ECM Degradation, and Inflammation in Articular Cartilage?Int J Mol Sci. 2018;19(8):2282. doi:10.3390/ijms19082282
   PubMed Web of Science ®Google Scholar
• BolducJA, CollinsJA, LoeserRF. Reactive oxygen species, aging and articular cartilage homeostasis. Free Radic Biol Med. 2019;132:73–82. doi:10.1016/j.freeradbiomed.2018.08.03830176344
   PubMed Web of Science ®Google Scholar
• ZahanOM, SerbanO, GhermanC, FodorD. The evaluation of oxidative stress in osteoarthritis. Med Pharm Rep. 2020;93(1):12–22.32133442
   PubMedGoogle Scholar
• SunK, LuoJ, JingX, et al. Astaxanthin protects against osteoarthritis via Nrf2: a guardian of cartilage homeostasis. Aging. 2019;11(22):10513–10531. doi:10.18632/aging.10247431772142
   PubMedGoogle Scholar
• KadiogluE, TeksenY, KocakC, KocakFE. Beneficial effects of bardoxolone methyl, an Nrf2 activator, on crush-related acute kidney injury in rats. Eur J Trauma Emerg Surg. 2021;47(1):241–250. doi:10.1007/s00068-019-01216-z31471671
   PubMed Web of Science ®Google Scholar
• WuQQ, WangY, SenitkoM, et al. Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1. Am J Physiol Renal Physiol. 2011;300(5):F1180–1192. doi:10.1152/ajprenal.00353.201021289052
   PubMed Web of Science ®Google Scholar